CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-19 | Schwab Andrew J. Director | Sale | −57,476 | $0.35 | $20K | 7,856,650 |
| 2026-08-19 | 5AM Partners VII, LLC 10% owner | Sale | −10,255 | $0.35 | $4K | 1,401,719 |
| 2026-08-19 | 5AM Partners VII, LLC 10% owner | Sale | −409 | $0.35 | $143 | 55,254 |
| 2026-08-19 | 5AM Partners VII, LLC 10% owner | Sale | −57,476 | $0.35 | $20K | 7,856,650 |
| 2026-08-18 | Schwab Andrew J. Director | Sale | −45,090 | $0.38 | $17K | 1,411,974 |
| 2026-08-18 | Schwab Andrew J. Director | Sale | −1,830 | $0.38 | $695 | 55,663 |
| 2026-08-18 | Schwab Andrew J. Director | Sale | −253,080 | $0.38 | $96K | 7,914,126 |
| 2026-08-18 | 5AM Partners VII, LLC 10% owner | Sale | −45,090 | $0.38 | $17K | 1,411,974 |
| 2026-08-18 | 5AM Partners VII, LLC 10% owner | Sale | −1,830 | $0.38 | $695 | 55,663 |
| 2026-08-18 | 5AM Partners VII, LLC 10% owner | Sale | −253,080 | $0.38 | $96K | 7,914,126 |
| 2026-08-07 | DHILLON PUNIT Chief Executive Officer | Grant or award | +1,090,000 | 1,419,823 | ||
| 2026-03-31 | Smith Karen L. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +17,004 | 17,004 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −17,004 | 0 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −75,000 | 0 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +7,100 | 7,100 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −7,100 | 0 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −200,000 | 0 |
Page 2 of 15 · 292 trades